Phase II Trial of Inhibition of Dipeptidyl Peptidase (DPP)-4 With Sitagliptin for the Prevention of Acute Graft Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 16 Sep 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Graft-versus-host disease
- Focus Adverse reactions
- 31 Aug 2016 Planned primary completion date changed from 1 Dec 2018 to 1 Feb 2019.
- 31 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 22 Feb 2016 New trial record